Linking Claims, Clinical Data Is Essential for a Learning Health System
April 28th 2017Is rubber meeting the road with big data in cancer care? “No…rather, not yet,” Green said at the 2017 Community Oncology Conference, April 26-27, held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland.
Read More
Oncology Practice Administrators Discuss Early Findings From the OCM
April 27th 2017At the 2017 Community Oncology Conference, practice administrators from 2 community clinics discussed the changes they made to their practice to accommodate the reporting requirements of the Oncology Care Model (OCM), and the follow-up planned as they work to implement changes.
Read More
UConn to Initiate a Personalized Vaccine Trial to Prevent Relapse in Advanced Ovarian Cancer
April 24th 2017The University of Connecticut has initiated recruitment for a phase I trial to test the safety and efficacy of OncoImmunome, a personalized vaccine designed to prevent relapse in patients diagnosed with Stage III or IV ovarian cancer.
Read More
FDA Wants Researchers to Rethink Patient Eligibility Criteria
April 20th 2017Although the purpose of eligibility criteria is to protect patients from unnecessary harm, define the study population, and allow researchers to collect safety and efficacy data for a specific population, unnecessary restriction may not capture the heterogeneity of real-world patients.
Read More
Do We Need Biomarkers to Predict Tumor Hyper-Progression Following Immunotherapy?
April 10th 2017A new study published in Clinical Cancer Research provides evidence that researchers can use biomarkers to identify patients whose tumors will grow at a faster rate following immunotherapy treatment.
Read More
AACR Study Finds Shift in Cancer Burden in HIV-Positive Individuals
April 6th 2017A study presented at the annual meeting of the American Association for Cancer Research predicts a shift in the number and the pattern of cancer incidence among those infected with the human immunodeficiency virus (HIV).
Read More
Mylan Faces Product Recall and Lawsuit Over PBM Deal
April 4th 2017Following news of a global recall of batches of EpiPen, Mylan NV has also been hit with a class action lawsuit claiming the company struck a deal with pharmacy benefit managers (PBMs) over the price of the life-saving medication.
Read More
Guideline Recommendations Purged Unnecessary Imaging in Early-Stage Breast Cancer
March 29th 2017A study published in the journal Cancer has found that the rate of advanced imaging at the time of breast cancer diagnosis reduced during the period between 2008 and 2015 in the state of Michigan.
Read More
New PARP Inhibitor, Niraparib, Approved as Maintenance Therapy for Ovarian and Other Cancers
March 28th 2017Results from the randomized NOVA trial convinced the FDA to approve niraparib (Zejula) as maintenance treatment for adult patients with recurrent epithelial ovarian, fallopian tube, or peritoneal cancer who are sensitive to platinum-based chemotherapy.
Read More
Personalized Care in Lung Cancer Is All About the Molecular Subtype
March 24th 2017At the 22nd Annual Conference of the National Comprehensive Cancer Network, held March 23-25, 2017, in Orlando, FL, Gregory J. Riely, MD, PhD, Memorial Sloan Kettering Cancer Center, spoke about the what, when, and how of biomarker testing in non-small cell lung cancer.
Read More
Radiation Therapy Updates for Breast Cancer in the NCCN Guidelines
March 24th 2017On the second day of the 22nd Annual Conference of the National Comprehensive Cancer Network (NCCN), Kilian E. Salerno, MD, of the Roswell Park Cancer Institute, walked the audience through updates to the NCCN Guidelines, explaining clinical situations in which radiation is indicated, appropriate targets of radiation treatment, and optimal approaches for minimizing toxicity.
Read More
Multigene Panels Important for Precision Cancer Care, Variance and Coverage Barriers Remain
March 23rd 2017While multigene panels are extremely important in precision cancer care, high levels of variance and insufficient insurance coverage are significant barriers to rapid adoption, according to Kenneth Offit, MD, MPH, from Memorial Sloan Kettering Cancer Center.
Read More